November 1, 2024
Joseph B. Martin Conference Center
77 Avenue Louis Pasteur, Boston, MA 02115

Staying abreast of the rapidly advancing field of prostate imaging is paramount to the successful staging and treatment of patients with prostate cancer. This one-day CME course, State of the Art Imaging in the Diagnosis and Management of Prostate Cancer, will discuss current and new developments in multiparametric MRI (mpMRI), MRI-ultrasound fusion biopsy, including transperineal biopsy, PSMA PET imaging, focal therapy treatment options, and other recent advances in imaging technology and diagnostics/therapeutics for prostate cancer. The course is designed to provide a focused, yet comprehensive advanced clinical review for practicing urologists, radiologists, medical oncologists, and radiation oncologists, as well as advanced practice providers. Participant learning and interaction will be encouraged through case reviews, question-and-answer sessions, and interaction with the course faculty.

Target Audience

This activity is intended for physicians, nurses, physician assistants, and other members of the healthcare team.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Define the most up-to-date imaging evaluation of patients with localized and advanced prostate cancer.
  • Assess upcoming novel imaging techniques for the evaluation of prostate cancer.
  • Describe imaging-based diagnostic and therapeutic procedural modalities including fusion biopsy and focal therapy.
  • Apply the most current state-of-the-art mpMRI imaging in the care of prostate cancer patients or those with a suspicion of prostate cancer.
  • Develop strategies for the healthcare team to incorporate MRI-ultrasound fusion prostate biopsy in clinical practice.
  • Integrate the most current pathophysiological and pathological concepts into the interpretation of mpMRI.

Course Directors

Adam Feldman, MD, MPH
Mukesh Harisinghani, MD